Atomoxetine and Methylphenidate Treatment in Children With ADHD: A Prospective, Randomized, Open-Label Trial
- 1 July 2002
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 41 (7) , 776-784
- https://doi.org/10.1097/00004583-200207000-00008
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response StudyPediatrics, 2001
- Validation of the ADHD Rating Scale as a clirlician administered and scored instrumentJournal of Attention Disorders, 2001
- Impairment and Deportment Responses to Different Methylphenidate Doses in Children With ADHD: The MTA Titration TrialJournal of the American Academy of Child & Adolescent Psychiatry, 2001
- CommentaryJournal of the American Academy of Child & Adolescent Psychiatry, 2000
- Pharmacological Alternatives to Psychostimulants for the Treatment of Attention-Deficit/Hyperactivity DisorderChild and Adolescent Psychiatric Clinics of North America, 2000
- Historical Development and Present Status of the Schedule for Affective Disorders and Schizophrenia for School-Age Children (K-SADS)Journal of the American Academy of Child & Adolescent Psychiatry, 2000
- ALTERNATIVE (NONSTIMULANT) MEDICATIONS IN THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER IN CHILDRENPediatric Clinics of North America, 1999
- Bupropion Hydrochloride in Attention Deficit Disorder with HyperactivityJournal of the American Academy of Child & Adolescent Psychiatry, 1996
- Computerized interviews as a method of assessing psychopathology in childrenComprehensive Psychiatry, 1995
- A Double-Blind Placebo Controlled Study of Desipramine in the Treatment of ADD: I. EfficacyJournal of the American Academy of Child & Adolescent Psychiatry, 1989